On Friday May 11, 2018, the Department of Health and Human Services (DHHS) held its annual listening session in advance of the upcoming World Health Assembly. Comments were limited to 2 minutes, with no time set aside for a question… Continue Reading
The following statement can be attributed to James Love, Director, on May 11, 2018. “The Trump Administration is proposing that the U.S. government advocate higher drug prices in foreign countries. We’ll have to see the details of how this effort… Continue Reading
These are provisions on the right to be forgotten in the European Union’s General Data Protection Regulation (GDPR). (KEI does not support the right to be forgotten). http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679&from=EN REGULATION (EU) 2016/679 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of… Continue Reading
On Friday, 20 April 2018 WIPO published a document (SCCR/26/3) entitled “Draft Action Plans on Limitations and Exceptions Through SCCR/39 (2nd Meeting in 2019)”. The draft action plans were prepared by Daren Tang (Singapore), the Chair of the Standing Committee… Continue Reading
In advance of the 71st World Health Assembly (21 May 2018 – 26 May 2018), the World Health Organization (WHO) published a document (A71/INF./2, 19 April 2018) entitled, Voluntary contributions by fund and by contributor, 2017. Total voluntary contributions to… Continue Reading
On 14 February 2018 and 16 February 2018, the World Trade Organization (WTO) conducted a Trade Policy Review (TPR) of Malaysia. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes… Continue Reading
The Supreme Court today delivered its ruling in the case of Oil States Energy Services, LLC v. Greene’s Energy Group, LLC, holding 7-2 that inter partes review (IPR) is constitutional and does not violate Article III nor the Seventh Amendment.… Continue Reading
On April 19, 2018, KEI filed a lawsuit against the National Institutes of Health (NIH) to block or invalidate an exclusive license of patents on a new chimeric antigen receptor T-cell (CAR T) therapy to Gilead Sciences. A copy of… Continue Reading
In a 2-1 ruling, the Court of Appeals for the Fourth Circuit has ruled that Maryland’s 2017 price-gouging law (HB 631) is unconstitutional. The law (Md. Code Ann., Health–General §§ 2-801 et seq.) had prohibited price gouging (defined as an… Continue Reading
KEI was invited to participate in the “WHO Global Dialogue on Partnerships for Sustainable Financing of Noncommunicable Disease (NCD) Prevention and Control,” which was held in Copenhagen, Denmark, April 9-11, 2018. A web page for the event is here. Overall,… Continue Reading